CClinicalTrials.gg
Not yet recruitingNCT07865429CBSSUpdated Oct 8, 2026

Efficiency of Calcium Hydroxide and Calcium Silicate-Based Sealers in Maxillary and Mandibular Molars on Post-Root Canal Pain

An interventional study of Calcium silicate based sealer in Calcium Silicate Based Sealer (CSBS), sponsored by Dow University of Health Sciences. Not yet recruiting at 1 site in Pakistan. Open to participants aged 18 Years to 45 Years. Per ClinicalTrials.gov, last updated 2026-10-08.

Sponsored by Dow University of Health Sciences · Not applicable, Interventional, and Treatment

Updated Oct 8, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
96
Allocation
Randomized
Ages
18 Years to 45 Years
Sex
All
01

Study summary

patients reported at department of Operative dentistry diagnosis section , patients coming to operative department of DIDC-DUHS with the chief complain of moderate to severe pain will be assessed .Complete history of each patient will be obtained along with clinical examination including percussion test, presence of swelling, sinus tract and mobility of tooth. Pulp sensitivity will be assessef. Periapical x-ray will be used to evaluate periapical status PAI score. . Following anesthesia, the tooth will be isolated with a rubber dam to maintain a dry operating field. An access cavity will then be prepared. The presence of bleeding within the pulp chamber will be regarded as an indicator of pulp vitality. The (WL) will be established using patency files . An endodontic motor (eight teeth E-connect) will be programmed for root canal instrumentation. Root canals will be irrigated with sodium hypochlorite (NaOCl). Root canals will be dried using paper points, and will take master cone periapical radiograph before final obturation procedure. For the CSBS group (CERASEAL; Meta Biomed Co., Cheongju, Korea), the sealer will be applied and a single cone will be used for obturation. For the CHBS group (Seal apex), the obturation will be completed via cold lateral condensation. The teeth will be restored with composite (LUNA SDI). Single operator will perform the complete procedure. Analgesic ibuprofen 400 mg (Brufen) will be prescribed to the patient in case of severe pain

02

Conditions studied

  • Calcium Silicate Based Sealer (CSBS)
03

In context

Lead sponsor

Dow University of Health Sciences is the lead sponsor of 171 studies on the registry; 31 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 45 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  1. Medically healthy patients
  2. Age: 18 to 45 years
  3. Vital Pulp with moderate to severe pre-operative pain score (VAS score 4-10 on EPT).
  4. Symptomatic apical periodontitis
  5. Mandibular and maxillary molars.
  6. Periapical index (PAI) scores 1-2.

Exclusion criteria

Exclusion Criteria:

  1. Patients experiencing root resorption
  2. Teeth with incomplete root development
  3. Calcified canals
  4. Severe malocclusion
  5. Pregnant or breastfeeding patients
  6. Patients who have used analgesics or anti-inflammatory medications within the past 24 hours
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
96 participants (estimated)

Study arms

  • Experimental
    Experimental :Calcium silicate based sealer

    Root canal sealer (CSBS)

    Other: Calcium silicate based sealer

  • Experimental
    Calcium hydroxide based sealer

    Root canal sealer (CHBS)

    Other: Calcium silicate based sealer

Interventions

  • OtherCalcium silicate based sealer

    Root canal sealer used in ENDODONTIC treatment with core material for obturation of root canals

06

What researchers measure

Primary outcomes

  1. Postoperative pain intensity measured using a Visual Analog Scale (VAS)

    Postoperative pain intensity will be assessed using a 10-cm Visual Analog Scale (VAS), ranging from 0 (no pain) to 10 (worst imaginable pain). Participants will record their pain intensity at 6, 24, and 48 hours and at 3 and 7 days after root canal treatment. VAS pain scores at each time point will be recorded and compared between the calcium silicate-based sealer and calcium hydroxide-based sealer groups.

    Time frame: 6,24 and 48 hours and after 3 and 7 days

07

Study locations

1 site
  • Dr Ayesha Tariq
    Karachi, 75100, Pakistan
    • Ayesha Tariq, Postgraduate Trainee- FCPS · Contact · ayesha.tariq157@gmail.com · 03361265165
    • Dr Farah Naz, HOD of Operative and Endodonti · Sub investigator
08

References and documents

Individual participant data

Plan to share: No — IPS will not be shared outside the study team to ensure patient confidentiality and privacy. Data will be used only for the purposes of this study and will remain restricted to the research team.

No publications or documents are linked to this record.

09

Updates

1 registry update since Sep 25, 2026
Registered
First appeared on the registry. No changes since
Oct 8, 2026
Show all 1 update
  1. Oct 8, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07865429
Lead sponsor
Dow University of Health Sciences
Responsible party
Ayesha Tariq (Resident, Department of Operative Dentistry, Dow University of Health Sciences) — Principal investigator
First posted
Oct 8, 2026
Start date
Oct 15, 2026 (estimated)
Primary completion
Mar 1, 2027 (estimated)
Completion
Jun 1, 2027 (estimated)
Last update
Oct 8, 2026

Study contacts

Ayesha Tariq, Recruiting
Contact
ayesha.tariq157@gmail.com
03350287343
Dr Ayesha Naz Tariq, Postgraduate Trainee- FCPS
principal investigator · Dow University of Health Sciences
Dr Ayesha Tariq, Postgraduate Trainee- FCPS
principal investigator · Dow University of Health Sciences

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion